About this episode
What if fat loss wasn’t just about eating less, but also about burning more at the same time? In this episode, we break down retatrutide, one of the most talked about compounds right now, and why it’s getting so much attention. You’ll learn how it works as a triple agonist targeting GLP-1, GIP, and glucagon receptors, and what that actually means for appetite, energy expenditure, and overall metabolic function. We also dive into how it compares to other well-known options, what the early research is showing, and the real-world considerations people aren’t talking about enough. If you want a clear, no-hype explanation of what makes retatrutide different and why it could represent a major shift in how we approach metabolism, this episode is for you.
